All In Biotech

Free tool

FAERS Monitor: Lodosyn

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017830 or its brand name (Lodosyn, Carbidopa). Reports on generic versions are filed under their own applications.

Reports

3,125

Serious

1,919

61% of reports

Hospitalization

933

Death reported

477

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hallucination306
  • drug ineffective292
  • fall255
  • death254
  • fatigue202
  • nausea202
  • dizziness198
  • parkinson^s disease180
  • confusional state154
  • tremor137
  • condition aggravated134
  • somnolence128
  • gait disturbance127
  • asthenia122
  • product dose omission issue119

Reports by year received

View as table
YearReports
200417
200526
200637
200738
200842
200950
201057
201162
201274
201358
201485
2015141
2016158
2017273
2018305
2019266
2020243
2021235
2022189
2023184
2024181
2025260
2026144

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,034 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
hallucinationSignal30627.424.77,764
confusional stateSignal1546.45.5704
tremorSignal1375.64.7511
fallSignal2555.24.6864
gait disturbanceSignal1274.53.8341
somnolenceSignal1284.33.6321
condition aggravatedSignal1343.02.5175
product dose omission issueSignal1192.72.3130
dizzinessSignal1982.72.3210
astheniaSignal1222.21.879
death2542.01.8128
fatigue2021.71.566
nausea2021.71.562
drug ineffective2921.51.350
parkinson^s disease1800.00.01,205,822

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.